{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T18:38:44Z","timestamp":1767897524495,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To determine the association between hyperglycemia, glycated albumin (GlyA) and retinopathy of prematurity (ROP). Prospective study of all infants under ROP screening from March 2017 to July 2019. All demographic, clinical and laboratory data were collected. Glucose was measured at birth and every 8\u00a0h for the first week and serum GlyA was evaluated at birth, 1st, 2nd and 4th weeks after birth. Reference range for GlyA was obtained. Univariate logistic regression was used to examine risk factors for ROP followed by multivariate regression. A total of 152 infants were included in the study. Median gestational age was 30\u00a0weeks and median birth weight 1240\u00a0g. Thirty-three infants (21.7%) had ROP. Hyperglycemia was present in 24 (72.7%) infants diagnosed with any ROP versus 6 (0.05%) in those without ROP. Median GlyA at birth, 1st, 2nd and 4th and respective reference ranges were 8.50% (6.00\u201312.65), 8.20% (5.32\u201311.67), 8.00% (5.32\u201310.00) and 7.90% (5.30\u20139.00) respectively. After multivariate logistic regression, hyperglycemia but not GlyA, remained a significant risk factor for ROP overpowering the other recognized risk factors (Exp (B) 28.062, 95% CI for Exp(B) 7.881\u201399.924 p\u2009&lt;\u20090.001). In our cohort, hyperglycemia but not GlyA, remained a significant risk factor for ROP overpowering the other recognized risk factors. \n<\/jats:p>","DOI":"10.1038\/s41598-021-01861-8","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T11:06:37Z","timestamp":1637060797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Correlation between hyperglycemia and glycated albumin with retinopathy of prematurity"],"prefix":"10.1038","volume":"11","author":[{"given":"Ana C.","family":"Almeida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela A.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Santini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarida","family":"Br\u00edzido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Correia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constan\u00e7a","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00eds Miguel","family":"Borrego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"key":"1861_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","volume":"84","author":"C Gilbert","year":"2008","unstructured":"Gilbert, C. Retinopathy of prematurity: A global perspective of the epidemics, population of babies at risk and implications for control. Early Hum. Dev. 84, 77\u201382. https:\/\/doi.org\/10.1016\/j.earlhumdev.2007.11.009 (2008).","journal-title":"Early Hum. Dev."},{"key":"1861_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/pr.2013.205","volume":"74","author":"H Blencowe","year":"2013","unstructured":"Blencowe, H., Lawn, J. E., Vazquez, T., Fielder, A. & Gilbert, C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr. Res. 74, 35\u201349. https:\/\/doi.org\/10.1038\/pr.2013.205 (2013).","journal-title":"Pediatr. Res."},{"key":"1861_CR3","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1542\/peds.2006-0628","volume":"118","author":"SP Hays","year":"2006","unstructured":"Hays, S. P., Smith, E. O. & Sunehag, A. L. Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants. Pediatrics 118, 1811\u20131818. https:\/\/doi.org\/10.1542\/peds.2006-0628 (2006).","journal-title":"Pediatrics"},{"issue":"715\u2013719","key":"1861_CR4","doi-asserted-by":"publisher","first-page":"e711","DOI":"10.1016\/j.jpeds.2010.04.032","volume":"157","author":"K Beardsall","year":"2010","unstructured":"Beardsall, K. et al. Prevalence and determinants of hyperglycemia in very low birth weight infants: Cohort analyses of the NIRTURE study. J. Pediatr. 157(715\u2013719), e711\u2013e713. https:\/\/doi.org\/10.1016\/j.jpeds.2010.04.032 (2010).","journal-title":"J. Pediatr."},{"key":"1861_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/bjophthalmol-2016-309187","volume":"102","author":"C Slidsborg","year":"2018","unstructured":"Slidsborg, C. et al. Early postnatal hyperglycaemia is a risk factor for treatment-demanding retinopathy of prematurity. Br. J. Ophthalmol. 102, 14\u201318. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-309187 (2018).","journal-title":"Br. J. Ophthalmol."},{"key":"1861_CR6","first-page":"429","volume":"17","author":"MK Sabzehei","year":"2014","unstructured":"Sabzehei, M. K. et al. Hyperglycemia in VLBW infants; incidence, risk factors and outcome. Arch. Iran Med. 17, 429\u2013434 (2014).","journal-title":"Arch. Iran Med."},{"key":"1861_CR7","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/ped.12371","volume":"56","author":"M Ahmadpour-Kacho","year":"2014","unstructured":"Ahmadpour-Kacho, M. et al. Correlation between hyperglycemia and retinopathy of prematurity. Pediatr. Int. 56, 726\u2013730. https:\/\/doi.org\/10.1111\/ped.12371 (2014).","journal-title":"Pediatr. Int."},{"key":"1861_CR8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/jp.2014.49","volume":"34","author":"L Mohsen","year":"2014","unstructured":"Mohsen, L. et al. A prospective study on hyperglycemia and retinopathy of prematurity. J. Perinatol. 34, 453\u2013457. https:\/\/doi.org\/10.1038\/jp.2014.49 (2014).","journal-title":"J. Perinatol."},{"key":"1861_CR9","doi-asserted-by":"publisher","first-page":"e79545","DOI":"10.1371\/journal.pone.0079545","volume":"8","author":"E Kermorvant-Duchemin","year":"2013","unstructured":"Kermorvant-Duchemin, E. et al. Neonatal hyperglycemia inhibits angiogenesis and induces inflammation and neuronal degeneration in the retina. PLoS ONE 8, e79545. https:\/\/doi.org\/10.1371\/journal.pone.0079545 (2013).","journal-title":"PLoS ONE"},{"key":"1861_CR10","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/jp.2013.77","volume":"33","author":"SE Ramel","year":"2013","unstructured":"Ramel, S. E. et al. Neonatal hyperglycemia and diminished long-term growth in very low birth weight preterm infants. J. Perinatol. 33, 882\u2013886. https:\/\/doi.org\/10.1038\/jp.2013.77 (2013).","journal-title":"J. Perinatol."},{"key":"1861_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1471-2431-13-78","volume":"13","author":"S Mohamed","year":"2013","unstructured":"Mohamed, S., Murray, J. C., Dagle, J. M. & Colaizy, T. Hyperglycemia as a risk factor for the development of retinopathy of prematurity. BMC Pediatr. 13, 78. https:\/\/doi.org\/10.1186\/1471-2431-13-78 (2013).","journal-title":"BMC Pediatr."},{"key":"1861_CR12","doi-asserted-by":"publisher","first-page":"436","DOI":"10.5301\/ejo.5000052","volume":"22","author":"S Vanhaesebrouck","year":"2012","unstructured":"Vanhaesebrouck, S. et al. Continuous glucose monitoring and retinopathy of prematurity. Eur. J. Ophthalmol. 22, 436\u2013440. https:\/\/doi.org\/10.5301\/ejo.5000052 (2012).","journal-title":"Eur. J. Ophthalmol."},{"key":"1861_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/jp.2010.152","volume":"31","author":"JW Kaempf","year":"2011","unstructured":"Kaempf, J. W. et al. Hyperglycemia, insulin and slower growth velocity may increase the risk of retinopathy of prematurity. J. Perinatol. 31, 251\u2013257. https:\/\/doi.org\/10.1038\/jp.2010.152 (2011).","journal-title":"J. Perinatol."},{"key":"1861_CR14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/jp.2011.19","volume":"31","author":"R Chavez-Valdez","year":"2011","unstructured":"Chavez-Valdez, R., McGowan, J., Cannon, E. & Lehmann, C. U. Contribution of early glycemic status in the development of severe retinopathy of prematurity in a cohort of ELBW infants. J. Perinatol. 31, 749\u2013756. https:\/\/doi.org\/10.1038\/jp.2011.19 (2011).","journal-title":"J. Perinatol."},{"key":"1861_CR15","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/sj.jp.7211594","volume":"26","author":"CL Blanco","year":"2006","unstructured":"Blanco, C. L., Baillargeon, J. G., Morrison, R. L. & Gong, A. K. Hyperglycemia in extremely low birth weight infants in a predominantly Hispanic population and related morbidities. J. Perinatol. 26, 737\u2013741. https:\/\/doi.org\/10.1038\/sj.jp.7211594 (2006).","journal-title":"J. Perinatol."},{"key":"1861_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000088199","volume":"89","author":"T Ertl","year":"2006","unstructured":"Ertl, T., Gyarmati, J., Gaal, V. & Szabo, I. Relationship between hyperglycemia and retinopathy of prematurity in very low birth weight infants. Biol. Neonate 89, 56\u201359. https:\/\/doi.org\/10.1159\/000088199 (2006).","journal-title":"Biol. Neonate"},{"key":"1861_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/sj.jp.7210879","volume":"23","author":"R Garg","year":"2003","unstructured":"Garg, R., Agthe, A. G., Donohue, P. K. & Lehmann, C. U. Hyperglycemia and retinopathy of prematurity in very low birth weight infants. J. Perinatol. 23, 186\u2013194. https:\/\/doi.org\/10.1038\/sj.jp.7210879 (2003).","journal-title":"J. Perinatol."},{"key":"1861_CR18","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1007\/s00125-011-2211-8","volume":"54","author":"S Suzuki","year":"2011","unstructured":"Suzuki, S. et al. Glycated albumin but not HbA1c reflects glycaemic control in patients with neonatal diabetes mellitus. Diabetologia 54, 2247\u20132253. https:\/\/doi.org\/10.1007\/s00125-011-2211-8 (2011).","journal-title":"Diabetologia"},{"key":"1861_CR19","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s12020-016-1091-6","volume":"55","author":"E Dozio","year":"2017","unstructured":"Dozio, E., Di Gaetano, N., Findeisen, P. & Corsi Romanelli, M. M. Glycated albumin: From biochemistry and laboratory medicine to clinical practice. Endocrine 55, 682\u2013690. https:\/\/doi.org\/10.1007\/s12020-016-1091-6 (2017).","journal-title":"Endocrine"},{"key":"1861_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1399-5448.2012.00895.x","volume":"14","author":"S Suzuki","year":"2013","unstructured":"Suzuki, S. et al. Glycated albumin is lower in infants than in adults and correlated with both age and serum albumin. Pediatr. Diabetes 14, 25\u201330. https:\/\/doi.org\/10.1111\/j.1399-5448.2012.00895.x (2013).","journal-title":"Pediatr. Diabetes"},{"key":"1861_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/pedi.12013","volume":"14","author":"S Suzuki","year":"2013","unstructured":"Suzuki, S. et al. Evaluation of glycated hemoglobin and fetal hemoglobin-adjusted HbA1c measurements in infants. Pediatr. Diabetes 14, 267\u2013272. https:\/\/doi.org\/10.1111\/pedi.12013 (2013).","journal-title":"Pediatr. Diabetes"},{"key":"1861_CR22","first-page":"1","volume-title":"Consenso Cl\u00ednico: Retinopatia da Prematuridade","author":"G Henriques","year":"2014","unstructured":"Henriques, G., Brito, C. & Teixeira, S. Consenso Cl\u00ednico: Retinopatia da Prematuridade 1\u201312 (Sociedade Portuguesa de Pediatria, 2014)."},{"key":"1861_CR23","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archopht.123.7.991","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity","year":"2005","unstructured":"International Committee for the Classification of Retinopathy of Prematurity. The International Classification of retinopathy of prematurity revisited. Arch. Ophthalmol. 123, 991\u2013999. https:\/\/doi.org\/10.1001\/archopht.123.7.991 (2005).","journal-title":"Arch. Ophthalmol."},{"key":"1861_CR24","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","volume":"121","author":"Early Treatment For Retinopathy Of Prematurity Cooperative Group","year":"2003","unstructured":"Early Treatment For Retinopathy Of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: Results of the early treatment for retinopathy of prematurity randomized trial. Arch. Ophthalmol. 121, 1684\u20131694. https:\/\/doi.org\/10.1001\/archopht.121.12.1684 (2003).","journal-title":"Arch. Ophthalmol."},{"key":"1861_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/s0009-8981(02)00207-3","volume":"324","author":"T Kouzuma","year":"2002","unstructured":"Kouzuma, T., Usami, T., Yamakoshi, M., Takahashi, M. & Imamura, S. An enzymatic method for the measurement of glycated albumin in biological samples. Clin. Chim. Acta 324, 61\u201371. https:\/\/doi.org\/10.1016\/s0009-8981(02)00207-3 (2002).","journal-title":"Clin. Chim. Acta"},{"key":"1861_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/BF03256353","volume":"14","author":"T Kohzuma","year":"2010","unstructured":"Kohzuma, T. & Koga, M. Lucica GA-L glycated albumin assay kit: A new diagnostic test for diabetes mellitus. Mol. Diagn. Ther. 14, 49\u201351. https:\/\/doi.org\/10.1007\/BF03256353 (2010).","journal-title":"Mol. Diagn. Ther."},{"key":"1861_CR27","first-page":"1","volume":"28","author":"LG Horowitz","year":"2010","unstructured":"Horowitz, L. G. et al. CLSI EP28-A3C:2010 defining, establishing, and verifying reference Intervals in the Clinical Laboratory. Clin. Lab. Stand. Inst. 28, 1\u201359 (2010).","journal-title":"Clin. Lab. Stand. Inst."},{"key":"1861_CR28","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1089\/dia.2018.0168","volume":"20","author":"M Jagla","year":"2018","unstructured":"Jagla, M. et al. Defining glycemic variability in very low-birthweight infants: Data from a continuous glucose monitoring system. Diabetes Technol. Ther. 20, 725\u2013730. https:\/\/doi.org\/10.1089\/dia.2018.0168 (2018).","journal-title":"Diabetes Technol. Ther."},{"key":"1861_CR29","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.140363","author":"B Cakir","year":"2020","unstructured":"Cakir, B. et al. IGF1, serum glucose, and retinopathy of prematurity in extremely preterm infants. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.140363 (2020).","journal-title":"JCI Insight."},{"key":"1861_CR30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.5935\/0004-2749.20150060","volume":"78","author":"GV Nicolaeva","year":"2015","unstructured":"Nicolaeva, G. V., Sidorenko, E. I. & Iosifovna, A. L. Influence of the blood glucose level on the development of retinopathy of prematurity in extremely premature children. Arq. Bras. Oftalmol. 78, 232\u2013235. https:\/\/doi.org\/10.5935\/0004-2749.20150060 (2015).","journal-title":"Arq. Bras. Oftalmol."},{"key":"1861_CR31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1055\/s-0035-1565999","volume":"33","author":"JH Lee","year":"2016","unstructured":"Lee, J. H. et al. Insulin, hyperglycemia, and severe retinopathy of prematurity in extremely low-birth-weight infants. Am. J. Perinatol. 33, 393\u2013400. https:\/\/doi.org\/10.1055\/s-0035-1565999 (2016).","journal-title":"Am. J. Perinatol."},{"key":"1861_CR32","first-page":"7","volume":"23","author":"M Jagla","year":"2019","unstructured":"Jagla, M., Szymonska, I., Starzec, K. & Kwinta, P. Impact of early glycemic variability on mortality and neurologic outcome of very low birth weight infants: Data from a continuous glucose monitoring system. Dev. Period. Med. 23, 7\u201314 (2019).","journal-title":"Dev. Period. Med."},{"key":"1861_CR33","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/IAE.0000000000002949","volume":"41","author":"M Jagla","year":"2021","unstructured":"Jagla, M., Szymonska, I., Starzec, K. & Kwinta, P. Glycemic variability is associated with treatment requiring retinopathy of prematurity: A case-control study. Retina 41, 711\u2013717. https:\/\/doi.org\/10.1097\/IAE.0000000000002949 (2021).","journal-title":"Retina"},{"key":"1861_CR34","doi-asserted-by":"publisher","first-page":"198","DOI":"10.4239\/wjd.v5.i2.198","volume":"5","author":"S Suzuki","year":"2014","unstructured":"Suzuki, S. & Koga, M. Glycemic control indicators in patients with neonatal diabetes mellitus. World J. Diabetes 5, 198\u2013208. https:\/\/doi.org\/10.4239\/wjd.v5.i2.198 (2014).","journal-title":"World J. Diabetes"},{"key":"1861_CR35","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1177\/0004563213512617","volume":"51","author":"S Suzuki","year":"2014","unstructured":"Suzuki, S. et al. Age-adjusted glycated albumin: A more robust parameter to establish glycaemic control in neonatal diabetes mellitus. Ann. Clin. Biochem. 51, 602\u2013605. https:\/\/doi.org\/10.1177\/0004563213512617 (2014).","journal-title":"Ann. Clin. Biochem."},{"key":"1861_CR36","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/jp.2010.144","volume":"31","author":"M Koga","year":"2011","unstructured":"Koga, M. et al. Measurement of glycated hemoglobin and glycated albumin in umbilical cord: Evaluation of the glycemic control indicators in neonates. J. Perinatol. 31, 430\u2013433. https:\/\/doi.org\/10.1038\/jp.2010.144 (2011).","journal-title":"J. Perinatol."},{"key":"1861_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jpeds.2003.10.017","volume":"144","author":"MS de Pipaon","year":"2004","unstructured":"de Pipaon, M. S. et al. Effects of antenatal steroids on protein metabolism in preterm infants on the first day of life. J. Pediatr. 144, 75\u201380. https:\/\/doi.org\/10.1016\/j.jpeds.2003.10.017 (2004).","journal-title":"J. Pediatr."},{"key":"1861_CR38","doi-asserted-by":"publisher","first-page":"G1157","DOI":"10.1152\/ajpgi.00300.2006","volume":"292","author":"JE Bunt","year":"2007","unstructured":"Bunt, J. E. et al. Albumin synthesis in preterm infants on the first day of life studied with [1-13C]leucine. Am. J. Physiol. Gastrointest Liver Physiol. 292, G1157\u2013G1161. https:\/\/doi.org\/10.1152\/ajpgi.00300.2006 (2007).","journal-title":"Am. J. Physiol. Gastrointest Liver Physiol."},{"key":"1861_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1203\/00006450-198701000-00012","volume":"21","author":"M Yudkoff","year":"1987","unstructured":"Yudkoff, M., Nissim, I., McNellis, W. & Polin, R. Albumin synthesis in premature infants: Determination of turnover with [15N]glycine. Pediatr Res. 21, 49\u201353. https:\/\/doi.org\/10.1203\/00006450-198701000-00012 (1987).","journal-title":"Pediatr Res."},{"key":"1861_CR40","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-1162","author":"A Galderisi","year":"2017","unstructured":"Galderisi, A. et al. Continuous glucose monitoring in very preterm infants: A randomized controlled trial. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2017-1162 (2017).","journal-title":"Pediatrics"},{"key":"1861_CR41","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3926","author":"RE Besser","year":"2016","unstructured":"Besser, R. E. et al. Prematurity and genetic testing for neonatal diabetes. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2015-3926 (2016).","journal-title":"Pediatrics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01861-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01861-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01861-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T17:18:05Z","timestamp":1670087885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01861-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1861"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-01861-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,16]]},"assertion":[{"value":"22 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22321"}}